X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47) 47
humans (41) 41
female (26) 26
cancer (24) 24
male (24) 24
liver neoplasms - genetics (23) 23
carcinoma, hepatocellular - genetics (20) 20
middle aged (19) 19
mutation (19) 19
gastroenterology & hepatology (16) 16
aged (15) 15
liver cancer (15) 15
liver neoplasms - pathology (15) 15
adult (14) 14
hepatocellular carcinoma (14) 14
carcinoma, hepatocellular - pathology (13) 13
genetic aspects (13) 13
life sciences (13) 13
oncology (13) 13
tumors (13) 13
classification (12) 12
cell line, tumor (11) 11
beta catenin - genetics (10) 10
expression (10) 10
liver (10) 10
prognosis (10) 10
risk factors (9) 9
somatic mutations (9) 9
gastroenterology and hepatology (8) 8
gene expression profiling (8) 8
human health and pathology (8) 8
hépatology and gastroenterology (8) 8
liver neoplasms - metabolism (8) 8
signal transduction (8) 8
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (7) 7
adenoma, liver cell - genetics (7) 7
adenoma, liver cell - pathology (7) 7
biomarkers, tumor - genetics (7) 7
carcinoma, hepatocellular - metabolism (7) 7
carcinoma, renal cell - drug therapy (7) 7
carcinoma, renal cell - genetics (7) 7
gene expression (7) 7
gene expression regulation, neoplastic (7) 7
genes (7) 7
hepatocellular adenoma (7) 7
kidney neoplasms - drug therapy (7) 7
kidney neoplasms - genetics (7) 7
mice (7) 7
treatment outcome (7) 7
aged, 80 and over (6) 6
animals (6) 6
beta catenin - metabolism (6) 6
biomarker (6) 6
carcinoma, hepatocellular (6) 6
genetics (6) 6
genomes (6) 6
hepatocyte nuclear factor 1-alpha - genetics (6) 6
interferon-alpha (6) 6
liver neoplasms (6) 6
metastasis (6) 6
pathology (6) 6
phenotype (6) 6
research (6) 6
transcriptome (6) 6
abridged index medicus (5) 5
adenoma (5) 5
analysis (5) 5
article (5) 5
beta-catenin (5) 5
carcinoma, renal cell (5) 5
dna mutational analysis (5) 5
gene (5) 5
gene mutations (5) 5
hepatocyte nuclear factor 1-alpha - metabolism (5) 5
immunohistochemistry (5) 5
inactivation (5) 5
liver neoplasms - classification (5) 5
mesh : humans (5) 5
mutations (5) 5
survival (5) 5
tumor cells, cultured (5) 5
urology & nephrology (5) 5
β-catenin (5) 5
activation (4) 4
adenoma, liver cell - metabolism (4) 4
biomarkers (4) 4
c-reactive protein (4) 4
cytokine receptor gp130 - genetics (4) 4
efficacy (4) 4
focal nodular hyperplasia (4) 4
gene-expression (4) 4
genetics & heredity (4) 4
glutamine (4) 4
growth (4) 4
hcc (4) 4
health aspects (4) 4
hepatocellular-carcinoma (4) 4
hepatocytes (4) 4
hepatoma (4) 4
indoles - therapeutic use (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 05/2015, Volume 47, Issue 5, pp. 505 - 511
Journal Article
Nature, ISSN 0028-0836, 01/2009, Volume 457, Issue 7226, pp. 200 - 204
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1315 - 13
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4364 - 4375
Purpose: Tivantinib was initially reported as a selective MET inhibitor and is under phase III evaluation in "MET-high" hepatocellular carcinoma (HCC)... 
BREAST-CANCER | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | TYROSINE KINASE | C-MET | ARQ 197 | THERAPEUTIC TARGETS | GENE AMPLIFICATION | ANTITUMOR-ACTIVITY | CYTOTOXIC ACTIVITY | CANCER CELL-LINES | Pyrrolidinones - adverse effects | Liver Neoplasms - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Humans | Liver Neoplasms - drug therapy | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Proto-Oncogene Proteins c-met - genetics | Whole Exome Sequencing | Pyrrolidinones - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - genetics | Carcinoma, Hepatocellular - pathology | Cell Line, Tumor | Liver Neoplasms - pathology | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Quinolines - adverse effects | Drug Resistance, Neoplasm - drug effects | Cell proliferation | Drugs | Biotechnology | Mitosis | Liver | Genes | Clinical trials | Hepatocellular carcinoma | Blockage | Gene sequencing | Anticancer properties | Liver cancer | Cell growth | Paclitaxel | Bioindicators | MET protein | Medical research | Sensitivity analysis | Vinblastine | Cell survival | Pharmacology | Tumor cell lines | Gene expression | Patients | Signaling | Sensitivity | Gene amplification | Hepatocytes | Experimental design | Cell lines | Biomarkers | Antitumor activity | Tumors | Cancer | Index Medicus
Journal Article